Myelofibrosis

Learn more about the newest discoveries and latest clinical insights in myelofibrosis (MF). Cancer Nursing Today provides up-to-date perspectives and information on transplant trends in MF, novel therapeutic targets, and more. From promising new treatments to risk factors and prognostics, explore the latest developments in MF care.

Higher Baseline Quality of Life Linked to Longer Overall Survival in Myelofibrosis
Higher baseline quality of life (QOL) independently predicted longer overall survival (OS) in patients with myelofibrosis (MF) who were enrolled in the COMFORT-I clinical trial, according to a recent study. The authors of the study, led by Heidi Kosiorek, MS, of Mayo Clinic, analyzed data from the COMFORT-I trial, which compared treatment with ruxolitinib to placebo in patients with intermediate-2 or high-risk MF. The results of the analysis were reported in a letter to the editor published in the British Journal of Haematology. ...
Advertisement

Latest News

Advertisement

Knowledge Hubs

Breast Cancer
Breast Cancer

Conference Highlights

June 16, 2022


Advertisement
Advertisement
Popular Stories